Attenuated PfSPZ Vaccine Induces Strain-Transcending T Cells and Durable Protection Against Heterologous Controlled Human Malaria Infection
Date
2017-03-07Publisher
Washington, D.C.: National Academy of SciencesType
Article
Metadata
Show full item recordDescription
Additional authors: Chakravarty, Sumana; DeZure, Adam; Enama, Mary E.; James, Eric R.; Billingsley, Peter F.; Gunasekera, Anusha; Manoj, Anita; Li, Minglin; Ruben, Adam J.; Li, Tao; Eappen, Abraham G.; Stafford, Richard E.; KC, Natasha; Murshedkar, Tooba; Mendoza, Floreliz H.; Gordon, Ingelise J.; Zephir, Kathryn L.; Holman, LaSonji A.; Plummer, Sarah H.; Hendel, Cynthia S.; Novik, Laura; Costner, Pamela J.M.; Saunders, Jamie G.; Berkowitz, Nina M.; Flynn, Barbara J.; Nason, Martha C.; Garver, Lindsay S.; Laurens, Matthew B.; Plowe, Christopher V.; Richie, Thomas L.; Graham, Barney S.; Roederer, Mario; Sim, B. Kim Lee; Ledgerwood, Julie E.; Hoffman, Stephen L.; Seder, Robert A.Citation
Lyke KE, Ishizuka AS, Berry AA, et al. (2017). Attenuated PfSPZ Vaccine Induces Strain-Transcending T Cells and Durable Protection Against Heterologous Controlled Human Malaria Infection. PNAS, 114(10), 2711-2716. doi: 10.1073/pnas.1615324114Keyword
controlled human malaria infection (CHMI)Plasmodium falciparum sporozoite vaccine (PfSPZ vaccine)
Malaria--prevention & control
Malaria Vaccines
Plasmodium
Sporozoites
T-Lymphocytes--immunology
Vaccines, Attenuated